Chlamydial Manipulation of Host Apoptosis
衣原体操纵宿主细胞凋亡
基本信息
- 批准号:7339909
- 负责人:
- 金额:$ 31.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-15 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAnimalsAntibodiesApoptosisAtherosclerosisBacterial Sexually Transmitted DiseasesBindingBiological AssayBlood VesselsCategoriesCell SurvivalCellsCenters for Disease Control and Prevention (U.S.)CerebrumCervix carcinomaChlamydiaChlamydia InfectionsChlamydophila pneumoniaeChlamydophila psittaciClinicalComplementComplexConditionCultured CellsCytosolDeveloped CountriesDeveloping CountriesEndopeptidasesEnsureEukaryotic CellExpression LibraryFecesFigs - dietaryFutureGenesGenitourinary systemGenomeGenomic LibraryGoalsGrowthHalf-LifeHealthHost DefenseHumanImmunityInduction of ApoptosisInfectionLifeLife Cycle StagesLinkLocationMammalian CellMapsOrganismPathologyPeptide HydrolasesPeptidesPhage DisplayPlayPneumoniaProteinsRandom Peptide LibrariesReagentResearch PersonnelResistanceRespiratory Tract InfectionsRoleSchemeScreening procedureSequence AnalysisStimulusStructureStudy SectionTechnologyTestingTimeVacuoleVirusWorkaerosolizedbasebiodefensecofactordesignexperienceimprovedinhibitor/antagonistmicrobialpathogenpreventprogramssuccesstrafficking
项目摘要
Mechanisms of Chlamydial Manipulation of Host Cell Apoptosis
Chlamydial infection in humans imposes a major health problem in both developing and
developed nations. Urogenital tract infection with C. trachomatis species is a leading cause of
sexually transmitted bacterial diseases and is also linked to certain type of cervical carcinoma while
respiratory infection with C. pneumoniae species is associated with atherosclerosis, a major
vascular condition for cardio-cerebral fatality. Although the species C. psittaci is primarily an animal
pathogen, humans are also susceptible to C. psittaci infection, developing life-threatening
pneumonia. Since humans can acquire infection via aerosolized animal feces that are contaminated
with C. psittaci organisms, CDC has once listed C. psittaci as a category B agent for biodefense.
These chlamydia-induced or -associated pathologies are largely due to Chlamydial ability to either
productively replicate or to achieve a long-term persistence within a cytoplasmic vacuole of
eukaryotic cells, which are aided by the Chlamydial unique intracellular biphasic life cycle and the
Chlamydial ability to evade host defense. The current proposal is designed to understand how
chlamydia evades a very important host defense effector mechanism¿apoptosis. We have
previously demonstrated that chlamydia possesses a potent antiapoptotic activity, which may
contribute to the Chlamydial ability to survive in the infected hosts for long periods of time. By
identifying the molecule(s) responsible for the Chlamydial antiapoptotic activity and understanding
how the antiapoptotic molecules work as proposed in the current project, we may be able to
develop reagents/approaches for blocking the Chlamydial antiapoptotic activity and preventing
chlamydia-induced pathologies.
宿主细胞凋亡的衣原体操纵机制
人类的衣原体感染不可能在发展中和
发达国家。泌尿生殖道被沙眼梭状芽孢杆菌感染是
性传播细菌疾病,也与某些类型的宫颈癌有关
肺炎梭状芽胞杆菌的呼吸道感染与动脉粥样硬化有关,这是主要的
心脏脑死亡的血管状况。尽管C. psittaci物种是主要动物
病原体,人类也容易受到C. psittaci感染的影响,发展生命
肺炎。由于人类可以通过被污染的动物粪便获得感染
使用C. psittaci生物,CDC曾经将C. psittaci列为生物粘剂B类代理。
这些衣原体引起或相关的病理主要是由于衣原体的能力
有效地复制或实现长期持久性的细胞质真空吸尘器
真核细胞,由衣原体独特的细胞内双相生命周期和
衣原体能够逃避东道国防御。当前的建议旨在了解如何
衣原体逃避了一种非常重要的宿主防御效应子机制。细胞凋亡。我们有
以前证明衣原体具有有效的抗凋亡活性,这可能
有助于长期在感染宿主中生存的衣原体能力。经过
识别负责衣原体抗凋亡活性的分子和理解
抗凋亡分子如何按照当前项目提出的工作,我们可能能够
开发用于阻断衣原体抗凋亡活性并防止的试剂/方法
衣原体引起的病理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUANGMING ZHONG其他文献
GUANGMING ZHONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUANGMING ZHONG', 18)}}的其他基金
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
免疫学研究生研究项目 (GRIP):培养研究生在学术界、工业界和政府中取得成功的职业生涯
- 批准号:
10186454 - 财政年份:2018
- 资助金额:
$ 31.29万 - 项目类别:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
免疫学研究生研究项目 (GRIP):培养研究生在学术界、工业界和政府中取得成功的职业生涯
- 批准号:
10410482 - 财政年份:2018
- 资助金额:
$ 31.29万 - 项目类别:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
免疫学研究生研究项目 (GRIP):培养研究生在学术界、工业界和政府中取得成功的职业生涯
- 批准号:
9757595 - 财政年份:2018
- 资助金额:
$ 31.29万 - 项目类别:
相似国自然基金
建立新型的基因编辑小鼠生物反应器广谱表达抗肠毒素B(SEB)单克隆抗体
- 批准号:31900676
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
TRAF6/mTOR双向调控巨噬细胞极化在放疗联合PD-1抗体诱导远隔效应中的作用及机制研究
- 批准号:81903135
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
超高效免疫磁MOFs纳米材料设计及其在动物源样品前处理中的应用研究
- 批准号:31873026
- 批准年份:2018
- 资助金额:61.0 万元
- 项目类别:面上项目
哺乳动物细胞抗体人工进化平台的研究
- 批准号:31870923
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
eCD4-mediated control of SIV infection in the brain
eCD4 介导的脑部 SIV 感染控制
- 批准号:
10698442 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Broadly neutralizing SARS-CoV-2 peptidic knobs
广泛中和 SARS-CoV-2 肽旋钮
- 批准号:
10735902 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别: